Promaxo
PrivateLast Round
Early Stage
VC
Mar 30, 2026
Est. Valuation
$226.9M
Total Funding Raised
$97.75M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Promaxo is a medical technology company that develops and commercializes portable, point-of-care MRI systems integrated with AI and robotics for prostate cancer diagnosis and treatment.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promaxo Comparables
Compare Promaxo with similar companies based on industry and business-model similarity.
Promaxo Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Stage VC | Mar 30, 2026 | ||||
| Series B Extension | Jul 10, 2024 | ||||
| Early Funding | Mar 25, 2024 | ||||
| Strategic | Oct 4, 2023 | ||||
| Series B Extension | Apr 7, 2022 | ||||
Series B Extension | Jan 13, 2021 |
Key People
Founding team and executive leadership
Promaxo Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keiretsu Forum | Series B Extension |
| Spark Growth Ventures | Series B Extension |
| iO Life Ventures | Series B Extension |
| Kineticos Ventures | Series B Extension |
| Zynext Ventures | Series B Extension, Early Funding |
| K2X Capital | Series B Extension |
| Almond Tree Capital | Series A, Series B, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 30, 2026
$27M raised in early stage venture capital round.
- Mar 1, 2026
Compact MRI platform cleared for office-based and outpatient procedures.
Promaxo Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Promaxo's valuation, stock price, and market status.